CTRI Number |
CTRI/2015/12/006450 [Registered on: 21/12/2015] Trial Registered Retrospectively |
Last Modified On: |
04/09/2015 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
observational |
Study Design |
Randomized, Parallel Group, Multiple Arm Trial |
Public Title of Study
|
Sedation for gastrointestinal endoscopies in children |
Scientific Title of Study
|
Comparison of Propofol-Ketamine combination versus Sevoflurane sedation for gastrointestinal endoscopies in children |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
IEC/05/14 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Vanya Chugh |
Designation |
Registrar, Fellow in Paediatric Anaesthesia |
Affiliation |
Lokmanya Tilak Municipal Medical College and General Hospital |
Address |
Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400022 India |
Phone |
9999977026 |
Fax |
|
Email |
vanya.shibu@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Anila Malde |
Designation |
Professor, Department of Anaesthesia |
Affiliation |
Lokmanya Tilak Municipal Medical College and General Hospital |
Address |
Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400022 India |
Phone |
9821085730 |
Fax |
|
Email |
dradmalde@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
vanya chugh |
Designation |
Registrar, Fellow in Paediatric Anaesthesia |
Affiliation |
Lokmanya Tilak Municipal Medical College and General Hospital |
Address |
Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400022 India |
Phone |
9999977026 |
Fax |
|
Email |
vanya.shibu@gmail.com |
|
Source of Monetary or Material Support
|
Lokmanya tilak Municipal Medical College and General Hospital , Sion, Mumbai. 400022 |
|
Primary Sponsor
|
Name |
Vanya Chugh |
Address |
Lokmanya tilak Municipal Medical College and General Hospital Department of anaesthesia, Sion, Mumbai, Maharashtra |
Type of Sponsor |
Other [Self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Vanya Chugh |
Lokmanya tilak Municipal Medical College and General Hospital |
Gastrointestinal endoscopy procedure room and paediatric surgery OT,Lokmanya tilak Municipal Medical College and General Hospital Mumbai MAHARASHTRA |
9999977026
vanya.shibu@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
lokmanya tilak Municipal Medical College and General Hospital staff and research society |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Paediatric patients for gastrointestinal endoscopies, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Propofol Ketamine Combination |
0.5 mg/kg IV Ketamine and 1mg/kg IV propofol as loading dose followed by incremental doses of 0.25-0.5mg/kg IV propofol alone for sedation during gastrointestinal endoscopy |
Intervention |
Sevoflurane |
Sevoflurane at 4% dial concentration in O2:N2O mixture(50:50) to begin with, followed by mixture of O2 in sevoflurane at 1-2% dial concentration for sedation during gastrointestinal endoscopy |
|
Inclusion Criteria
|
Age From |
6.00 Month(s) |
Age To |
18.00 Year(s) |
Gender |
Both |
Details |
Patients undergoing elective upper or lower GI endoscopic procedures.
American Society of Anaesthesiologists class I & II (I: healthy; II: single, controlled disease state).
Parents and guardians of the patient consenting for the procedure.
|
|
ExclusionCriteria |
Details |
a. American Society of Anaesthesiologists class III and above.
b. Known hypersensitivity to propofol or ketamine or sevoflurane or h/s/o egg allergy.
c. Patients with following conditions:
i. Airway related problems.
ii. Respiratory disorders.
iii. Cardiovascular disorders.
iv. Central nervous system disorders/neurologic impairment.
v. Acute febrile illness.
vi. Bleeding oesophageal varices.
d. History of recent hepatitis
e. Renal insufficiency
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Time to emergence from procedural sedation
|
1) Emergence time - From end of procedure till achievement of Modified Ramsay Sedation Score ≤ 3.
2) Time to respond to light painful stimulus
3) Time to cough
4) Time to spontaneous eye opening
5) Time to achievement of purposeful limb movements
6) Time to child becoming oriented (older children)
|
|
Secondary Outcome
|
Outcome |
TimePoints |
1) Effectiveness of sedation in terms of Induction time, success of Induction, success of maintenance
2) Safety in terms of occurrence of complications |
•Induction time: Administration of study drugs to fixation of eyeballs, adequate jaw relaxation and Modified Ramsay Sedation Score 4 or 5.
•Success of Induction: Induction doses sufficient to allow easy passage of endoscope. Need of changeover from one group to the other will be considered as failure.
•Success of maintenance: Maintenance doses sufficient to carry out the procedure. Need of changeover from one group to the other will be considered as failure.
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
03/04/2014 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
Publication Details
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
Introduction:
Gastrointestinal
(GI) Endoscopy is a well-established procedure done for both diagnostic and
therapeutic purposes. Mild sedation is adequate for adults being subjected to
endoscopies but it becomes difficult to obtain cooperation from a child
undergoing the same. Multiple studies have been done to develop the ideal method for
procedural sedation in children. Though both propofol-ketamine combination
and sevoflurane have been widely used for procedural sedation, there are no
trials comparing the two of them. Hence, this observational study has been planned
to compare the efficacy and safety from intravenous propofol-ketamine with
inhalational sevoflurane for procedural sedation in paediatric GI endoscopies.
Aim:
To evaluate and
compare the efficacy and safety of intravenous propofol-ketamine versus Inhalational
sevoflurane for deep sedation in paediatric GI endoscopic procedures.
Objectives:
To observe
following parameters in patients subjected for GI endoscopy under deep sedation
with either intravenous propofol-ketamine or inhalational sevoflurane:
1)
Effectiveness
in terms of: Induction time, effectiveness of agents for
induction (insertion of endoscope), effectiveness of agents for maintenance, endoscopist’s comfort with agents used.
2) Safety:
Occurrence of complications like respiratory, haemodynamic fluctuations, need
for restraint, use of additional anaesthetic agents, conversion to tracheal
tube general anaesthesia
3)
Emergence and recovery: In terms of degree of
sedation, time to recovery,post
procedure agitation score, post procedure nausea vomiting.
Methodology:
All the patients are premedicated, under controlled environment, in the
endoscopy suite with oral Midazolam 0.5 mg/kg dose, 30 minutes prior to entry
to the procedure room. In the operating room, patients in IV group receive
Ketamine-Propofol (Group KP) 0.5 mg/kg IV ketamine and 1mg/kg IV propofol as
loading dose followed by incremental doses of 0.25-0.5mg/kg IV propofol alone
as per the requirement. We will observe for adequacy of loading dose as
fixation of eyeballs and adequate jaw relaxation for scope insertion.Patients
in inhalational group receive Sevoflurane (Group S) at 4% dial concentration in
O2:N2O mixture(50:50) to begin with. Adequacy of sedation
will be fixation of eyeballs and
adequate jaw relaxation for the scope insertion. Sedation is maintained using a
mixture of O2 in sevoflurane at 1-2% dial concentration with
endoscopy mask.
Primary outome measure: Recovery from sedation
Secondary
outcome measures: effectiveness of sedation, occurrence of complications.
Statistical Analysis: Parametric data will be presented as mean ±
standard deviation data and analyzed using unpaired t test. Repeated
measurements data will be analyzed using paired t test and binary data will be
analyzed using Chi-square test. Nonparametric data will be analyzed
using Mann Whitney U test.
Lacuna
In Existing Knowledge: Numerous
agents have been used for procedural sedation for GI endoscopy. However, there
is lack of consensus regarding the most suitable technique.. Using this study,
an attempt is being made to determine an effective and safe technique for GI
endoscopic procedural sedation in children.
|